The Pfizer and Moderna mRNA vaccines can be used by adults and children as young as 6 months. The Novavax shot is a more ...
Moderna reported better third-quarter results than expected Thursday morning, as the vaccine maker reported a surprise profit for the period amid its efforts to cut costs and $1.8 billion in sales of ...
Sales of Moderna’s COVID-19 shot exceeded expectations, but the company’s launch of its new RSV vaccine has started slowly.
Moderna crushed third-quarter expectations on Thursday and turned around a surprise profit. But Moderna stock pulled back.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback